A January 2025 Cell Metabolism study reveals obesity induces lasting epigenetic changes in T cells, causing persistent inflammation even after weight loss, challenging current recovery assumptions. Ne...
A new study reveals that dasatinib and quercetin (D+Q) cause demyelination in mice, raising safety concerns as over 30 clinical trials test the combo for age-related diseases. A study in Nature Aging ...
Recent research uncovers strong correlations between gut bacteria composition and physical function in seniors, suggesting microbiome-targeted interventions could combat frailty. Can the bacteria in y...
Senolytics like dasatinib and quercetin are transforming dermatology from cosmetic fixes to true biological rejuvenation, with recent trials showing improved skin elasticity and potential for treating...
A comparative study reveals that dasatinib-quercetin reduces senescence and fibrosis in intervertebral disc degeneration, while navitoclax shows no benefit, highlighting DQ’s potential for affor...
New single-cell studies reveal distinct immune aging trajectories in women and men, with implications for personalized vaccines, autoimmune monitoring, and cancer screening. The immune system ages dif...
Recent research reveals how mitochondrial decline accelerates cellular senescence in blood vessels, driving conditions like atherosclerosis and blood-brain barrier leakage, with emerging therapies tar...
A Danish register-based study reveals flu vaccination reduces heart attack and stroke risk by curbing inflammation, offering a key strategy for aging populations and preventive health. Recent data sho...
Stanford University researchers have engineered NK and T cells with metabolite-sensing receptors like GPR183, enhancing tumor infiltration in mice and offering new hope for CAR-T therapies in solid tu...
Exploring recent advances in senolytic and senomorphic therapies, including dasatinib-quercetin and immune-based approaches, to combat age-related diseases like Alzheimer’s and sarcopenia. New t...